Senior insider sale
Chief Medical Officer at DENALI THERAPEUTICS INC. — senior position signals high conviction
$7.30M
339.49K shares
What this filing means
HO CAROLE plans to sell 339.49K shares of DENALI THERAPEUTICS INC. valued at approximately $7.30M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/5/2026ACC: 0001950047-26-000957
Officer· Chief Medical Officer
Since Aug 2018
339.49K
Shares to sell
$7.30M
Approx. market value
39.49K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Exercise of options under a registered plan
Cash
2/5/2026
39.49KTotal acquired39.49K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/5/2026 | Exercise of options under a registered plan Cash | 39.49K | — |
| Total | 39.49K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
150K
Market value
$3.18M
2/4/2026
—Completed
Units to sell
150K
Market value
$3.32M
2/3/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
39.49K
Market value
$801.4K
2/5/2026
Total
Units
339.49K
Value
$7.30M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/4/2026 | 150K | $3.18M | — | Completed |
2/3/2026 | 150K | $3.32M | — | Completed |
| Planned — Approximate Date | ||||
2/5/2026 | 39.49K | $801.4K | NASDAQ | Planned |
| Total | 339.49K | $7.30M | ||